Efficient assessment of drug safety and toxicity can be complex and time-consuming. We develop and deliver integrated cardiovascular services to enhance the assessment of cardiac safety and toxicity of drug candidates.
Learn more about our Safety ServicesWe combine our cardiovascular and neural cell knowledge with expertise in large-scale manufacturing to enable drug developers to bring predictive human disease biology earlier into the drug discovery process.
Stefan is the Chief Executive Officer of Ncardia. He obtained his MSc and PhD (both cum laude) in stem cell biology under the supervision of Prof. Dr Mummery, and brings over a decade of experience in stem cell research and product development. As key inventor of the underlying Pluriomics technologies he has been instrumental in the establishment and growth of the company.
Johan is Chief Services Officer at Ncardia. He has a background in drug metabolism and kinetics and vast industry experience, and is in charge of all Ncardia Service offerings.
Roman is our Director of BD & Sales in Europe. He has a background in biology and has gained commercial experience in the stem cell industry. He is the direct contact person for our German-speaking customers.
Celine is Director of Strategic Alliances & Partnering. After completing her PhD in immunology and molecular biology she moved to business development and developed several successful partnerships with Biotech and Pharma.
Mieke is Product Marketing Manager at Ncardia. She holds a PhD obtained at the Laboratory for Molecular Stem Cell Biology at the Heinrich-Heine University of Düsseldorf, and has extended commercial and marketing experience from several leading biotech companies.
Alexandre has over 15 years' experience in the biotech industry where he occupied various functions. At Ncardia he is responsible for Sales and Business Development of our products and services in Southern Europe.
Tessa has extensive expertise in hiPSC-derived cardiac cells, and cell-based assays for drug safety and efficacy screenings. She has completed her Masters in Bio-Pharmaceutical Sciences at Leiden University and leverages her expertise supporting partners and customers in performing their assays.
Ralf has extended expertise in hiPSC-derived cardiac cells, and cell-based assays for drug safety and efficacy screenings. He obtained his PhD from the University of Bonn, where he focused on aortic vascular smooth muscle cells. With over 16 years of experience with pluripotent stem cell-derived cardiomyocytes, he uses this knowledge in supporting our customers and partners.
Silvina obtained her PhD in neurobiology. She gained experience in applied solutions for the pharmaceutical industry while working at Galapagos and Charles River. As a Project Manager at Ncardia, she uses her experience in our Safety and Efficacy Services that we offer to our customers.
Heather joins our US team as Business Development Manager. She has extensive experience in the area of stem cell technologies and sales, which further strengthens Ncardia's presence in the US market.
Below is a selection of our latest news, and the events where you can meet us.
Inspiration from a selection of our latest innovations.